Suppr超能文献

霍奇金病治疗后非霍奇金淋巴瘤的发生

The development of non-Hodgkin's lymphoma following therapy for Hodgkin's disease.

作者信息

Kim H D, Bedetti C D, Boggs D R

出版信息

Cancer. 1980 Dec 15;46(12):2596-602. doi: 10.1002/1097-0142(19801215)46:12<2596::aid-cncr2820461211>3.0.co;2-t.

Abstract

Three patients developed non-Hodgkin's lymphoma (NHL) 3-6 years after treatment for Hodgkin's disease (HD). In no instance was there evidence of recurrence of HD following the initial chemotherapy or radiotherapy. None of these patients had received both radiation therapy and chemotherapy. The histologic classification of the developing of the developing NHL for the three patients was (1) diffuse, poorly differentiated lymphocytic, (2) nodular histocytic, and (3) nodular, poorly differentiated lymphocytic. In no instance was there any histologic similarity to the original HD. Perhaps most important with respect to histology was the easily demonstrable presence of Reed-Sternberg cells at the time of original diagnosis and their absence with onset of NHL. All patients responded well to conventional chemotherapy for NHL and are alive at 23+, 37+, and 65+ months after that secondary diagnosis. This report, when coupled with at least ten other such reported patients, suggests that NHL may be a relatively uncommon but significant complication of therapy for HD and must be distinguished for recurrence of HD.

摘要

三名患者在接受霍奇金病(HD)治疗后3至6年发生了非霍奇金淋巴瘤(NHL)。在任何情况下,初始化疗或放疗后均无HD复发的证据。这些患者均未同时接受放疗和化疗。三名患者发生的NHL的组织学分类为:(1)弥漫性、低分化淋巴细胞型,(2)结节性组织细胞型,(3)结节性、低分化淋巴细胞型。在任何情况下,均未发现与原始HD有任何组织学相似性。就组织学而言,也许最重要的是在最初诊断时很容易证实存在里德-施特恩伯格细胞,而在NHL发病时则不存在。所有患者对NHL的传统化疗反应良好,在二次诊断后23个月以上、37个月以上和65个月以上仍存活。本报告与至少其他十名此类报告患者的情况相结合,表明NHL可能是HD治疗中一种相对罕见但重要的并发症,必须与HD的复发相鉴别。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验